Cargando…

Carotid Artery Stenting: A Single-Center Experience

BACKGROUND: Carotid artery stenting is now used as an alternative to surgical endarterectomy. This study was done to assess the feasibility, safety, and immediate and late clinical outcomes in patients undergoing carotid stenting. METHODS: Between July 2008 and December 2009, a total of 40 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Namazi, Mohammad Hassan, Mohammadi, Afsane, Safi, Morteza, Vakili, Hossein, Saadat, Habib, Amini, Adbollatif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466848/
https://www.ncbi.nlm.nih.gov/pubmed/23074591
_version_ 1782245713399250944
author Namazi, Mohammad Hassan
Mohammadi, Afsane
Safi, Morteza
Vakili, Hossein
Saadat, Habib
Amini, Adbollatif
author_facet Namazi, Mohammad Hassan
Mohammadi, Afsane
Safi, Morteza
Vakili, Hossein
Saadat, Habib
Amini, Adbollatif
author_sort Namazi, Mohammad Hassan
collection PubMed
description BACKGROUND: Carotid artery stenting is now used as an alternative to surgical endarterectomy. This study was done to assess the feasibility, safety, and immediate and late clinical outcomes in patients undergoing carotid stenting. METHODS: Between July 2008 and December 2009, a total of 40 patients (20 male, mean age: 65 ± 11 years, 19 symptomatic, and 90% high risk for endarterectomy) underwent carotid artery stenting with different embolic protection devices and carotid stents. Thirty-seven patients had coronary artery disease. Technical success rate, stroke/death/myocardial infarction rate at 30 days, access-site complications, and contrast-induced nephropathy were assessed. For the evaluation of the influence of experience in carotid artery stenting on complications, the patients were divided into two groups: Group 1 included the first 20 treated patients and Group 2 comprised the remainder of the patients. RESULTS: The overall technical success rate was 100%. The cumulative in-hospital stroke death rate was 7.5% (n = 3: 2 deaths and 1 major stroke). Complications were more frequent in Group 1 (2/20, 10%; 2 deaths) than in Group 2 (1/20, 5%; 1 major stroke), but this was not statistically significant (p value = 0.09). No access-site complications occurred, and mild contrast-induced nephropathy occurred in 3 patients (7.5%). No major stroke or neurological deaths occurred during a mean follow-up of 12 months. CONCLUSION: Carotid stenting seemed feasible and relatively safe in our experience. Advanced experience in carotid artery stenting appears to confer an acceptable peri-procedural stroke-death rate.
format Online
Article
Text
id pubmed-3466848
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-34668482012-10-16 Carotid Artery Stenting: A Single-Center Experience Namazi, Mohammad Hassan Mohammadi, Afsane Safi, Morteza Vakili, Hossein Saadat, Habib Amini, Adbollatif J Tehran Heart Cent Original Article BACKGROUND: Carotid artery stenting is now used as an alternative to surgical endarterectomy. This study was done to assess the feasibility, safety, and immediate and late clinical outcomes in patients undergoing carotid stenting. METHODS: Between July 2008 and December 2009, a total of 40 patients (20 male, mean age: 65 ± 11 years, 19 symptomatic, and 90% high risk for endarterectomy) underwent carotid artery stenting with different embolic protection devices and carotid stents. Thirty-seven patients had coronary artery disease. Technical success rate, stroke/death/myocardial infarction rate at 30 days, access-site complications, and contrast-induced nephropathy were assessed. For the evaluation of the influence of experience in carotid artery stenting on complications, the patients were divided into two groups: Group 1 included the first 20 treated patients and Group 2 comprised the remainder of the patients. RESULTS: The overall technical success rate was 100%. The cumulative in-hospital stroke death rate was 7.5% (n = 3: 2 deaths and 1 major stroke). Complications were more frequent in Group 1 (2/20, 10%; 2 deaths) than in Group 2 (1/20, 5%; 1 major stroke), but this was not statistically significant (p value = 0.09). No access-site complications occurred, and mild contrast-induced nephropathy occurred in 3 patients (7.5%). No major stroke or neurological deaths occurred during a mean follow-up of 12 months. CONCLUSION: Carotid stenting seemed feasible and relatively safe in our experience. Advanced experience in carotid artery stenting appears to confer an acceptable peri-procedural stroke-death rate. Tehran University of Medical Sciences 2010 2010-09-30 /pmc/articles/PMC3466848/ /pubmed/23074591 Text en Copyright © Tehran Heart Center, Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Namazi, Mohammad Hassan
Mohammadi, Afsane
Safi, Morteza
Vakili, Hossein
Saadat, Habib
Amini, Adbollatif
Carotid Artery Stenting: A Single-Center Experience
title Carotid Artery Stenting: A Single-Center Experience
title_full Carotid Artery Stenting: A Single-Center Experience
title_fullStr Carotid Artery Stenting: A Single-Center Experience
title_full_unstemmed Carotid Artery Stenting: A Single-Center Experience
title_short Carotid Artery Stenting: A Single-Center Experience
title_sort carotid artery stenting: a single-center experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466848/
https://www.ncbi.nlm.nih.gov/pubmed/23074591
work_keys_str_mv AT namazimohammadhassan carotidarterystentingasinglecenterexperience
AT mohammadiafsane carotidarterystentingasinglecenterexperience
AT safimorteza carotidarterystentingasinglecenterexperience
AT vakilihossein carotidarterystentingasinglecenterexperience
AT saadathabib carotidarterystentingasinglecenterexperience
AT aminiadbollatif carotidarterystentingasinglecenterexperience